Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Ardent Health
ARDT
Ardent Health
Aging Demographics And Medicaid Expansion Will Transform US Healthcare
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
20 Jul 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$23.00
45.7% undervalued
intrinsic discount
15 Aug
US$12.48
Loading
1Y
-28.7%
7D
3.7%
Author's Valuation
US$23.0
45.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$23.0
45.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-119m
7b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue US$7.4b
Earnings US$342.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.23%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.58%
Calculation
US$342.86m
Earnings '28
x
12.04x
PE Ratio '28
=
US$4.13b
Market Cap '28
US$4.13b
Market Cap '28
/
144.14m
No. shares '28
=
US$28.64
Share Price '28
US$28.64
Share Price '28
Discounted to 2025 @ 7.61% p.a.
=
US$22.98
Fair Value '25